Abbisko Cayman Limited (HKG:2256)
Hong Kong · Delayed Price · Currency is HKD 7.48
-0.10 (-1.32%)
Oct 21, 2026, 2:41 PM HKT
Abbisko Cayman Market Cap
Abbisko Cayman has a market cap or net worth of 4.95 billion as of October 20, 2026. It is the 12,964th most valuable company in the world and the 611th biggest in Hong Kong. Its market cap has decreased by 52.95% in one year.
Market Cap
4.95B
Enterprise Value
2.64B
Revenue
112.29M
Global Rank
Country Rank
#611 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since October 15, 2021, Abbisko Cayman's market cap has decreased from 8.71B to 4.95B, a decrease of -43.12%. That is a compound annual growth rate of -10.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 4.95B | -43.36% |
| Dec 31, 2025 | 8.75B | 204.13% |
| Dec 31, 2024 | 2.88B | 21.63% |
| Dec 29, 2023 | 2.36B | 4.97% |
| Dec 30, 2022 | 2.25B | -64.77% |
| Dec 31, 2021 | 6.39B | -26.60% |
| Oct 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alphamab Oncology | 6.84B |
| CARsgen Therapeutics Holdings | 6.78B |
| Ascletis Pharma | 6.05B |
| Shaanxi Micot Pharmaceutical Technology | 5.82B |
| LongBio Pharma (Suzhou) | 5.63B |
| TenNor Therapeutics (Suzhou) | 5.40B |
| CK Life Sciences Int'l., (Holdings) | 4.90B |
| Jacobio Pharmaceuticals Group | 4.13B |